Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000265753 | SCV000464039 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Counsyl | RCV000265753 | SCV000790717 | uncertain significance | Autosomal recessive polycystic kidney disease | 2017-04-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000265753 | SCV001232187 | likely benign | Autosomal recessive polycystic kidney disease | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001526423 | SCV001736783 | uncertain significance | Polycystic kidney disease 4 | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001526423 | SCV001806438 | uncertain significance | Polycystic kidney disease 4 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Victorian Clinical Genetics Services, |
RCV001526423 | SCV002769166 | uncertain significance | Polycystic kidney disease 4 | 2019-08-28 | criteria provided, single submitter | clinical testing | A heterozygous missense variant was identified, NM_138694.3(PKHD1):c.9705T>A in exon 58 of 67 of the PKHD1 gene. This substitution is predicted to create a moderate amino acid change from asparagine to lysine at position 3235 of the protein, NP_619639.3(PKHD1):p.(Asn3235Lys). The asparagine at this position has moderate conservation (100 vertebrates, UCSC), but is not situated in a known functional domain. In silico software predictions of the pathogenicity of this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.015% (35 heterozygotes, 1 homozygote). The variant has been previously reported as both a VUS (ClinVar) and in a homozygote patient with polycystic kidney disease (Alehabib, E., et al. (2017)). Subsequent analysis of parental samples indicated this variant was maternally inherited. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS). |
Natera, |
RCV000265753 | SCV002075537 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-07-17 | no assertion criteria provided | clinical testing |